Key result
Clinical MMVD is linked to ~6.6-fold higher odds of ventricular arrhythmias on Holter monitoring.
Why the study?
Does clinical heart failure severity or left atrial enlargement increase the prevalence of ventricular and supraventricular arrhythmias on 24-hour Holter monitoring in dogs with myxomatous mitral valve disease?
Observational (n=36)
Yes
Does clinical heart failure severity or left atrial enlargement increase the prevalence of ventricular and supraventricular arrhythmias on 24-hour Holter monitoring in dogs with myxomatous mitral valve disease?
In dogs with myxomatous mitral valve disease, 24-hour Holter monitoring is superior to resting ECG for heart rate assessment and arrhythmia detection, demonstrating that ventricular arrhythmias are associated with clinical heart failure and supraventricular arrhythmias are associated with left atrial enlargement.
Answers are grounded in this paper and cite their sources.
Clinical MMVD associates with higher ventricular arrhythmia prevalence on Holter in dogs; leaves open whether monitoring informs staging or therapy.
OBJECTIVE: Describe the presence of arrhythmias in dogs with myxomatous mitral valve disease (MMVD) and the potential association with class of heart failure and left atrial enlargement. Compare the standard electrocardiogram (ECG) with Holter monitoring for assessing heart rate (HR). EXPERIMENTAL PROCEDURE: The study group of 36 dogs weighing less than 20 kg was divided into MMVD and no clinical signs (preclinical) or MMVD and clinical signs (clinical). A standard echocardiogram, ECG and 24-h Holter recording were obtained in all dogs. RESULTS: Minimum and mean Holter HRs were higher in the clinical group than in the preclinical group. Clinical dogs had more ventricular arrhythmias than preclinical dogs. An enlarged left atrium was associated with the presence of more supraventricular arrhythmias. CONCLUSIONS: Arrhythmias are a common finding in dogs with MMVD and Holter monitoring is a reliable tool for both HR monitoring and diagnosis.
No takes yet. Share an insight, caveat, or question.
Crosara et al. (2010) conducted an observational in Canine myxomatous mitral valve disease (MMVD) (n=36). Clinical heart failure (ISACHC class 2 and 3) in MMVD evaluated by 24-h Holter monitoring vs. Preclinical MMVD (ISACHC class 1a and 1b) was evaluated on Presence of ventricular arrhythmias on 24-hour Holter monitoring (OR 6.62, p=0.01). Dogs with clinical myxomatous mitral valve disease had a higher prevalence of ventricular arrhythmias on 24-h Holter than preclinical dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: